propane has been researched along with Benign Paroxysmal Peritonitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balshaw, R; Butrimiene, I; Dember, LM; Garceau, D; Gorevic, PD; Hauck, W; Hawkins, PN; Hazenberg, BP; Lachmann, HJ; Lesnyak, O; Livneh, A; Merlini, G; Obici, L; Puéchal, X; Skinner, M | 1 |
| Manenti, L; Tansinda, P; Vaglio, A | 1 |
1 trial(s) available for propane and Benign Paroxysmal Peritonitis
| Article | Year |
|---|---|
Eprodisate for the treatment of renal disease in AA amyloidosis.
Topics: Amyloidosis; Arthritis, Rheumatoid; Creatinine; Disease Progression; Double-Blind Method; Familial Mediterranean Fever; Female; Glycosaminoglycans; Humans; Kaplan-Meier Estimate; Kidney Diseases; Kidney Failure, Chronic; Male; Middle Aged; Propane; Proportional Hazards Models; Proteinuria; Serum Amyloid A Protein; Sulfonic Acids | 2007 |
1 other study(ies) available for propane and Benign Paroxysmal Peritonitis
| Article | Year |
|---|---|
Eprodisate in AA amyloidosis.
Topics: Amyloidosis; Colchicine; Familial Mediterranean Fever; Humans; Kidney Diseases; Kidney Failure, Chronic; Propane; Proportional Hazards Models; Sulfonic Acids | 2007 |